Amanote Research
Register
Sign In
P1.01-109 Phase I Study of Apatinib Plus Gefitinib as First-Line Therapy in Patients With EGFR Mutant Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.666
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
H. Zhao
Z. Zhang
S. Li
W. Fang
Y. Ma
Y. Zhang
Y. Yang
F. Luo
Y. Huang
L. Zhang
Publisher
Elsevier BV
